Loading...
ImmTACs: Novel bi-specific agents for targeted cancer therapy
Our expanding knowledge of the immune system is guiding a new era of targeted anticancer therapies. Here, we describe our recent work on a novel class of anticancer agents termed ImmTACs. These molecules combine the power of picomolar-affinity TCR-based antigen recognition with the immune-activating...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601161/ https://ncbi.nlm.nih.gov/pubmed/23525668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22891 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|